Month: October 2019

Australian healthcare shares fall as report on aged care flags regulatory change

Shares of Australia’s biggest listed aged care providers fell on Friday after a government-backed inquiry strongly criticized care of the elderly and vulnerable, raising expectations of a far-reaching regulatory overhaul.

Merck loses bid to revive $2.54 billion patent verdict against Gilead

A U.S. appeals court on Wednesday dealt a major blow to Merck & Co Inc as it upheld a ruling that threw out a $2.54 billion jury verdict the drugmaker had won against Gilead Sciences Inc .

Amgen posts higher biosimilar sales, ends neuroscience program

Amgen Inc on Tuesday said competition for its older drugs sent third-quarter revenue down 3%, but biosimilar sales were strong and the quarterly results were ahead of Wall Street estimates.

Justice Department issues grand jury subpoenas in J&J opioid probe: filing

Johnson & Johnson received grand jury subpoenas in August from the U.S. attorney’s office for the Eastern District of New York related to its opioid medication policies, the company said in a regulatory filing on Monday.

Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell

Facing off against a plaintiff’s lawyer for the first time about Johnson & Johnson’s Baby Powder, the company’s Chief Executive Alex Gorsky earlier this month insisted that the company’s iconic brand was safe.

Two charities to pay $6 million to resolve U.S. pharma kickback probe

Two charities will pay $6 million to resolve claims they operated as pass-throughs for seven pharmaceutical companies to pay kickbacks to Medicare patients using their high-priced medications, the U.S. Justice Department said on Friday.

Direct-to-consumer genetic test results may be unreliable

(Reuters Health) – Genetic tests sold online or in stores may produce false results, warn genetics experts in the UK.

FDA investigating whether Zantac causes carcinogens to form in users

The U.S. Food and Drug Administration is investigating whether the popular heartburn drug Zantac causes carcinogens to form in the bodies of users, in an effort to fully understand the risks posed by the already recalled drug, the agency’s spokesman said on Thursday.

New York, states reach $700 million settlement with Reckitt over opioid probes

New York and five other states have reached a $700 million settlement deal with Reckitt Benckiser over allegations that the drug distributor improperly marketed a drug to treat opioid addiction, New York Attorney General Letitia James said on Wednesday.

Women giving birth in low-income countries often endure abuse

(Reuters Health) – Women are often mistreated during labor and delivery at hospitals in low-income countries, a new study suggests.

ARE YOU READY? GET IT NOW!
Recieve NuPeak Pro’s Free Nootropics Report
Your Information will never be shared with any third party.